The Effects of Nutritional Supplementation and Drug Abuse on HIV

NCT00149656 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 878

Last updated 2013-04-29

No results posted yet for this study

Summary

The purpose of this trial is to determine whether supplementation with multivitamins and selenium will delay disease progression in HIV infected individuals in Botswana. The study will also assess how drug abuse modifies the effect of nutritional supplementation on HIV disease progression.

Conditions

  • HIV Infections
  • Substance-Related Disorders

Interventions

DIETARY_SUPPLEMENT

Multivitamins

dietary supplement of multivitamins

DIETARY_SUPPLEMENT

Selenium

dietary supplement of selenium only

OTHER

Placebo

placebo pill

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • Florida International University

    lead OTHER

Principal Investigators

  • Marianna K. Baum, PhD · Florida International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2010-07-31
Completion
2013-04-30

Countries

  • Botswana

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149656 on ClinicalTrials.gov